Persistent idiopathic facial pain
Therapeutic area
Neurology
Rare disease
Yes
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- Yes
- Listing at source
- Listed
- Condition name
- Persistent idiopathic facial pain
- Therapeutic area
- Neurology
- persistent idiopathic facial pain
- AFP
- PIFP
- atypical facial pain
- All therapeutic areas
- Neurology
- Severity
- Mild
- MONDO ID
- MONDO:0018362
- Parent condition
- MONDO:0005071
Related records
Broader conditions (6)
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Human disease
- Idiopathic disease
- Nervous system disorder
Trials (11)
- A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
- An Innovative Cognitive-Behavioral Treatment For Chronic Orofacial Pain
- Atypical Orofacial Pain Diagnostics and Differentiation.
- Deciphering Persistent Orofacial Pain - PIFP
- Efficacy and Safety of ATNC05 in Treatment of Atypical Facial Pain
- Ganglionic Local Opioid Analgesia at the Ganglion Cervicale Superius
- Pattern of AFP in Chhidren Admitted at Sohag University Hospital
- PD-1 Antibody + Apatinib Mesylate in 2+ Line Serum AFP-elevated Gastric Adenocarcinoma
- PD-1 Antibody + XELOX in 1st Line Serum A-fetoprotein (AFP)-Elevated Gastric or Gastroesophageal Junction Adenocarcinoma
- Transnasal Versus Suprazygomatic SPG Block in Persistant Idiopathic Facial Pain
- Ultrasound Guided Trigeminal Nerve Block for Typical or Atypical Facial Pain